Pharmacokinetics of amprenavir and lopinavir in combination with nevirapine in highly pretreated HIV-infected patientsFÄTKENHEUER, Gerd; RÖMER, Katja; KAMPS, Robert et al.AIDS (London). 2001, Vol 15, Num 17, pp 2334-2335, issn 0269-9370Article

Maraviroc. CommentaryCARTER, Natalie J; KEATING, Gillian M; NELSON, Mark et al.Drugs (Basel). 2007, Vol 67, Num 15, pp 2277-2290, issn 0012-6667, 14 p.Article

Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresisSEIFERT, Harald; CORNELY, Oliver; SEGGEWISS, Kerstin et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 1, pp 118-123, issn 0095-1137, 6 p.Article

Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cellsKAPPERT, Kai; CAGLAYAN, Evren; BÄUMER, Anselm T et al.AIDS (London). 2004, Vol 18, Num 3, pp 403-411, issn 0269-9370, 9 p.Article

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimensWYEN, Christoph; HENDRA, Heidy; ROCKSTROH, Juergen et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 9, pp 2092-2098, issn 0305-7453, 7 p.Article

HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, GermanySCHÜLTER, Eugen; OETTE, Mark; KAISER, Rolf et al.Medical microbiology and immunology. 2011, Vol 200, Num 4, pp 219-223, issn 0300-8584, 5 p.Article

Do activities of cytochrome P450 (CYP)3A, CYP2D6 and P-glycoprotein differ between healthy volunteers and HIV-infected patients?JETTER, Alexander; FÄTKENHEUER, Gerd; WYEN, Christoph et al.Antiviral therapy (London). 2010, Vol 15, Num 7, pp 975-983, issn 1359-6535, 9 p.Article

Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patientsVAN DER LEE, Manon; SANKATSING, Raaj; DE GROOT, Eric et al.Antiviral therapy (London). 2007, Vol 12, Num 7, pp 1127-1132, issn 1359-6535, 6 p.Article

Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDSLIPTROTT, Neill J; PUSHPAKOM, Sudeep; BACK, David J et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 1, pp 10-19, issn 1744-6872, 10 p.Article

Evolution of raltegravir resistance during therapySICHTIG, Nadine; SIERRA, Saleta; ESSER, Stefan et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, Num 1, pp 25-32, issn 0305-7453, 8 p.Article

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 InfectionFÄTKENHEUER, Gerd; NELSON, Mark; BELLOS, Nicholaos et al.The New England journal of medicine. 2008, Vol 359, Num 14, pp 1442-1455, issn 0028-4793, 14 p.Article

Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adultsSCHÜRMANN, Dirk; FÄTKENHEUER, Gerd; HOFFMANN, Christian et al.AIDS (London). 2007, Vol 21, Num 10, pp 1293-1299, issn 0269-9370, 7 p.Article

Trends of prevalence of primary HIV drug resistance in GermanySAGIR, Abdurrahman; OETTE, Mark; PFISTER, Herbert et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 4, pp 843-848, issn 0305-7453, 6 p.Article

Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemiaMOBIUS, Ulrike; LUBACH-RUITMAN, Margrit; SCHMIDT, Reinhold E et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 174-180, issn 1525-4135, 7 p.Article

Central venous catheter (CVC)-related infections in neutropenic patients: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)FÄTKENHEUER, Gerd; BUCHHEIDT, Dieter; WEISSINGER, Florian et al.Annals of hematology. Supplement. 2003, Vol 82, Num 2, pp S149-S157, issn 0945-8077Article

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3⁺ T Regulatory Cells Correlates with Progressive DiseaseSCHULZE ZUR WIESCH, Julian; THOMSSEN, Adriana; DEGEN, Olaf et al.Journal of virology. 2011, Vol 85, Num 3, pp 1287-1297, issn 0022-538X, 11 p.Article

Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2HARDY, W. David; GULICK, Roy M; MAYER, Howard et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 5, pp 558-564, issn 1525-4135, 7 p.Article

Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic SuppressionMOORE, David M; HARRIS, Ross; CHENE, Geneviève et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 3, pp 357-363, issn 1525-4135, 7 p.Article

Increased Interferon Alpha Expression in Circulating Plasmacytoid Dendritic Cells of HIV-1-Infected PatientsLEHMANN, Clara; HARPER, Jill M; TAUBERT, Dirk et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 5, pp 522-530, issn 1525-4135, 9 p.Article

Safety, Tolerability, and Preliminary Efficacy of 48 Weeks of Etravirine Therapy in a Phase IIb Dose-Ranging Study Involving Treatment-Experienced Patients with HIV-1 InfectionMONTANER, Julio; YENI, Patrick; WOODFALL, Brian et al.Clinical infectious diseases. 2008, Vol 47, Num 7, pp 969-978, issn 1058-4838, 10 p.Article

Optimal use of maraviroc in clinical practiceSORIANO, Vincent; GERETTI, Anna Maria; PERNO, Carlo-Federico et al.AIDS (London). 2008, Vol 22, Num 17, pp 2231-2240, issn 0269-9370, 10 p.Article

Posaconazole concentrations in the central nervous systemRÜPING, Maria J. G. T; ALBERMANN, Nadine; ULLMANN, Andrew J et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 6, pp 1468-1470, issn 0305-7453, 3 p.Article

Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young womanELTER, Thomas; SIENIAWSKI, Michal; CORNELY, Oliver A et al.International journal of antimicrobial agents. 2006, Vol 28, Num 3, pp 262-265, issn 0924-8579, 4 p.Article

Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: A randomized controlled multicenter trial in patients with febrile neutropeniaCOMELY, Oliver A; WICKE, Thomas; DIEHL, Volker et al.International journal of hematology. 2004, Vol 79, Num 1, pp 74-78, issn 0925-5710, 5 p.Article

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trialPOLLARD, Richard B; ROCKSTROH, Jürgen K; ARASTEH, Keikawus et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 4, pp 291-300, issn 1473-3099, 10 p.Article